| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 04/11/2002 | WO2001062924A3 Human g protein-coupled receptors |
| 04/11/2002 | WO2001060844A3 Peptide and nucleic acid coding therefor for the detection, diagnosis and therapy of diseases of the nervous system |
| 04/11/2002 | WO2001058946A3 Polynucleotides and polypeptides encoded thereby |
| 04/11/2002 | WO2001058937A3 Interferon-alpha induced genes |
| 04/11/2002 | WO2001058477A3 Immunization of an individual against carcinoma and the preliminary stages thereof |
| 04/11/2002 | WO2001057209A3 Novel family of proteins, called atip, nucleic sequences coding for same and uses thereof |
| 04/11/2002 | WO2001055320A3 Nucleic acids, proteins, and antibodies |
| 04/11/2002 | WO2001055316A3 Nucleic acids, proteins, and antibodies |
| 04/11/2002 | WO2001053835A3 Methods for detecting cancer of the central nervous system |
| 04/11/2002 | WO2001036616A3 Acid nucleic construct bearing a system regulating the expression of a gene |
| 04/11/2002 | WO2000063689A9 Detecting and suppressing malignancy based on expression of spleen tyrosine kinase (syk) |
| 04/11/2002 | WO2000052210A3 Methods for targeting rna molecules |
| 04/11/2002 | WO2000038518A9 Efficient and stable (in vivo) gene transfer to cardiomyocytes using recombinant adeno-associated virus vectors |
| 04/11/2002 | US20020042926 Ovary-specific genes and proteins |
| 04/11/2002 | US20020042812 Apparatus, method and system for voice over a network having provider selection and disputeless billing |
| 04/11/2002 | US20020042505 Novel human ion channel protein and polynucleotides encoding the same |
| 04/11/2002 | US20020042388 Gene therapy for liver, lungs, tissues; determination, calibration of solution turbidity |
| 04/11/2002 | US20020042387 Administering nucleic acid as antiinflammatory agent |
| 04/11/2002 | US20020042386 Genetic engineering |
| 04/11/2002 | US20020042384 Integrin-targeting vectors having transfection activity |
| 04/11/2002 | US20020042383 Antiinflammatory agents |
| 04/11/2002 | US20020042382 Sequestrin |
| 04/11/2002 | US20020042360 Antitumor agents |
| 04/11/2002 | US20020042139 Amplifying cell transformation efficiency; obtain cells, transform with replication defective vectors, monitor transformed cells for preferential gene expression |
| 04/11/2002 | US20020042138 Inducing globin gene expression in cells; obtain cells, incubate with preferential nucleotide sequences, monitor cells for amplified globin expression |
| 04/11/2002 | US20020042136 Retroviral vectors comprising an enhanced 3' transcription termination structure |
| 04/11/2002 | US20020042130 Propagating preferential aggregations; obtain aggregation, incubate with buffy coat cells, propagate, recover genetically engineered cells |
| 04/11/2002 | US20020042114 Novel human protein kinases |
| 04/11/2002 | US20020042098 32253 transferase family members and uses therefor |
| 04/11/2002 | US20020042096 Nucleic acids, proteins, and antibodies |
| 04/11/2002 | US20020042093 Polypeptide; for use in diagnosis, treatment or prevention of thyroid tumors and defects |
| 04/11/2002 | US20020042057 Nucleotide sequences for use in the treatment of cardiomyopathies |
| 04/11/2002 | US20020041894 Method of forcing the reverse transport of cholesterol from a body part to the liver while avoiding harmful disruptions of hepatic cholesterol homeostasis and pharmaceutical compositions and kit related thereto |
| 04/11/2002 | US20020041884 Adenovirus formulations |
| 04/11/2002 | US20020041876 Modulation of angiogenesis |
| 04/11/2002 | US20020041869 Methods for treating cells |
| 04/11/2002 | US20020041867 Microencapsulated dna for vaccination and gene therapy |
| 04/11/2002 | DE10100586C1 Inhibiting gene expression in cells, useful for e.g. treating tumors, by introducing double-stranded complementary oligoRNA having unpaired terminal bases |
| 04/11/2002 | DE10046970A1 New human P2Y1li gene, useful for treatment and diagnosis of associated diseases, and related proteins, antibodies and modulators, encodes G protein-coupled receptor |
| 04/11/2002 | DE10045803A1 New proteins binding specifically to the ED-b fibronectin domain, are cell adhesion and proliferation mediators useful e.g. in screening tests |
| 04/11/2002 | DE10043481A1 Humaner Antikörper gegen Endoglin (CD105) und seine Verwendung Human antibodies against endoglin (CD105) and its use |
| 04/11/2002 | CA2425712A1 Methods of modulating apoptosis by administration of relaxin agonists or antagonists |
| 04/11/2002 | CA2425152A1 Highly expressible genes |
| 04/11/2002 | CA2425092A1 Regulation of cell proliferation and differentiation using topically applied nucleic acid molecules |
| 04/11/2002 | CA2425072A1 Wt1 fusion polypeptides and methods for wt1 immunotherapy |
| 04/11/2002 | CA2424953A1 Novel human proteases and polynucleotides encoding the same |
| 04/11/2002 | CA2424952A1 Listeria inocua, genome and applications |
| 04/11/2002 | CA2424936A1 Vaccine composition comprising an immunologically active substance embedded in microparticles consisting of starch with reduced molecular weight |
| 04/11/2002 | CA2424892A1 Biodegradable microparticles for controlled release administration, with purified amylopectin-based starch of reduced molecular weight |
| 04/11/2002 | CA2424781A1 Methods of isolating bipotent hepatic progenitor cells |
| 04/11/2002 | CA2424738A1 Retroviral vectors containing internal ribosomal entry sites |
| 04/11/2002 | CA2424693A1 Induction of blood vessel formation by polynucleotides encoding sphingosine kinases |
| 04/11/2002 | CA2424668A1 Targeting molecules for adenoviral vectors |
| 04/11/2002 | CA2424604A1 Modulation of the transcription of pro-inflammatory gene products |
| 04/11/2002 | CA2424216A1 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 04/11/2002 | CA2424199A1 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 04/11/2002 | CA2423677A1 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins |
| 04/11/2002 | CA2423436A1 Methods and compositions for modulating t cell activation and uses thereof |
| 04/11/2002 | CA2358860A1 Dna-binding protein yb-1-containing collagen accumulation inhibitors |
| 04/10/2002 | EP1195440A1 Gene delivery vectors for stem cells |
| 04/10/2002 | EP1195439A2 Retroviral vector with heterologous sequences between the retroviral primer binding site and the retroviral splice donor site |
| 04/10/2002 | EP1195438A1 Genetic immunisation against cervical carcinoma |
| 04/10/2002 | EP1195161A2 Anti-IgE vaccines |
| 04/10/2002 | EP1194590A2 Diagnostics and therapeutics for diseases associated with an il-1 inflammatory haplotype |
| 04/10/2002 | EP1194581A2 Respiratory syncytial viruses expressing immune modulatory molecules |
| 04/10/2002 | EP1194573A2 Arrays of catalytic or pre-catalytic nucleic acids |
| 04/10/2002 | EP1194571A1 Prostase vaccine |
| 04/10/2002 | EP1194568A1 Tankyrase homolog protein (thp), nucleic acids, and methods related to the same |
| 04/10/2002 | EP1194566A2 Gene therapy for enhancing and/or inducing angiogenesis |
| 04/10/2002 | EP1194560A2 Antigenic neisserial peptides |
| 04/10/2002 | EP1194554A1 Delivery of trefoil peptides |
| 04/10/2002 | EP1194552A1 Nucleic acids coding for peptides having the biological activity of sorbin |
| 04/10/2002 | EP1194547A2 Cdna sequences of two interacting fancip2 and fancip3 of the fanconi anemia complementation group a protein |
| 04/10/2002 | EP1194546A1 Compositions corresponding to a calcium transporter and methods of making and using same |
| 04/10/2002 | EP1194545A2 Secreted polypeptides and corresponding polynucleotides |
| 04/10/2002 | EP1194544A1 Chimeric oca-b transcription factors |
| 04/10/2002 | EP1194543A2 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS |
| 04/10/2002 | EP1194529A1 Composition for the preservation of infectious recombinant adenoviruses |
| 04/10/2002 | EP1194527A1 Stress-responsive induction of a therapeutic agent and methods of use |
| 04/10/2002 | EP1194448A1 Seven transmembrane receptor genes |
| 04/10/2002 | EP1194173A1 X-ray guided drug delivery |
| 04/10/2002 | EP1194172A1 Compositions and methods for the treatment or prevention of autoimmune disorders |
| 04/10/2002 | EP1194168A2 Methods and products for manipulating uncoupling protein expression |
| 04/10/2002 | EP1194122A1 Methods for preparation of lipid-encapsulated therapeutic agents |
| 04/10/2002 | EP1178116A9 Sid nucleic acids and polypeptides selected from a pathogenic strain of hepatitis C virus and applications thereof |
| 04/10/2002 | EP1076694A4 Methods and substances for preventing and treating autoimmune disease |
| 04/10/2002 | EP0935458B1 Compositions containing at least one nucleic acid |
| 04/10/2002 | EP0694070B1 Recombinant alphavirus vectors |
| 04/10/2002 | EP0607206B1 Composition for inserting nucleic acid complexes into higher eucaryotic cells |
| 04/10/2002 | CN1344326A Petroviral vectors comprising functional and non-functional splice donor and splce acceptor sites |
| 04/10/2002 | CN1344317A 多肽 Polypeptide |
| 04/10/2002 | CN1344166A Use of enterobacterium protein ompA associated with antigen for generating antiviral, antiparasitic or antitumoral cytotoxic response |
| 04/09/2002 | US6369295 Uses of transgenic mouse containing a type X collagen mutant |
| 04/09/2002 | US6369209 Oligonucleotides having A-DNA form and B-DNA form conformational geometry |
| 04/09/2002 | US6369208 Influenza endonuclease apatamer that inhibits influenza endonuclease and is resistant to cleavage by said enzyme |
| 04/09/2002 | US6369039 Saturated solution; catheter |
| 04/09/2002 | US6369038 Closed antisense and sense oligonucleotides and their applications |
| 04/09/2002 | US6369027 Osteoprotegerin |
| 04/09/2002 | US6368863 Reagents and methods for modulating gene expression through RNA mimicry |
| 04/09/2002 | US6368855 MHC class II antigen presenting cells containing oligonucleotides which inhibit Ii protein expression |